Back to News
Market Impact: 0.25
CAPR Securities Losses: Capricor Therapeutics Investors with Losses on their Investment are Reminded to Contact BFA Law by September 28 Deadline in Securities Fraud Class Action
Source: GlobeNewswire
Legal & LitigationHealthcare & Biotech
Capricor Therapeutics investors are being reminded of a September 28 deadline to contact BFA Law regarding a securities-fraud class action. The notice signals potential litigation exposure and investor-loss claims, creating a negative overhang for the biotech company's shares, though the article provides no alleged damages, operational metrics, or case details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
CAPR-0.90
More News
- Jefferies upgrades Tempus AI stock rating to hold, raises price target to $70
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Bloomberg News Now
- Karyopharm stock rating cut to neutral by Rodman on bankruptcy
- RA Capital Management sells $9.13M in Lenz Therapeutics shares
- The Pentagon is investigating if rogue freezers are tied to cyberattacks in France. Another wave of hacks is hitting supermarkets across Europe